Skip To Main Content
Guoshu Yin on Muck Rack

Guoshu Yin

As seen in: Nature, Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Guoshu

Contact Guoshu, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Real-world glycemic control, exploratory cardiorenal indicators, and safety of polyethylene glycol loxenatide versus semaglutide in type 2 diabetes patients: a Chinese two-center retrospective cohort study

|
By Zelin Yu, Jing Xu, Guoshu Yin, De Cai, Hongyan Jiang, Kai Ling, Duoyi Fu, Chujia Lin, Jianqin Chen, Yeye Zhuo
| Frontiers
Abstract Objective: To compare the real-world efficacy and safety of high dose once-weekly glucagon-like peptide-1 receptor agonists polyethylene glycol loxenatide (PEG-Loxe) and subcutaneous (s.c.) semaglutide in patients with suboptimally controlled type 2 diabetes mellitus (T2DM). Methods: We conducted a retrospective cohort China two-center study.
Open in Who Shared Issue with article?

Inhibition of Slug effectively targets leukemia stem cells via the Slc13a3/ROS signaling pathway

|
By Chen Wu, Pei Zhu, Zhonghui Zhang, Guoshu Yin
| Nature Verified
Abstract Leukemia stem cells (LSCs) are the rare populations of acute myeloid leukemia (AML) cells that are able to initiate, maintain, and propagate AML. Targeting LSCs is a promising approach for preventing AML relapse and improving long-term outcomes. While Slug, a zinc-finger transcription repressor, negatively regulates the self-renewal of normal hematopoietic stem cells, its functions in AML are still unknown.
Open in Who Shared Issue with article?
See all 2 articles